Description / Application
DMH1 is a pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine bearing quinolin-4-yl and 4-isopropyloxyphenyl substituents at positions 3 and 6 respectively. It has a role as an antineoplastic agent, a protein kinase inhibitor and a bone morphogenetic protein receptor antagonist. It is a member of quinolines, an aromatic ether and a pyrazolopyrimidine.
Identities
| Alternative Name | VU0364852 |
|---|---|
| Molecular Formula | C24H20N4O |
| Molecular Weight | 380.44 |
| MFCD | MFCD18384963 |
Transport
| DOT UN Number | UN2811 |
|---|---|
| Hazard Class | 6.1 |
| Packing Group | III |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P264;P270;P301+P310;P321;P330;P405;P501 |